Journal of Translational Medicine and Research
Vol. 22, Nr. 1, March 2017
Surgical Options in Synchronous Liver Metastases from Colorectal Cancer
Sorin Alexandrescu, Andrei Diaconescu, Irinel Popescu
REVIEW, March 2017
Article DOI: 10.21614/jtmr-22-1-109
Currently, the treatment of liver metastases of colorectal cancer (CRC) requires a multidisciplinary approach and should be individualized for each patient. Liver resection provides 5 years survival rates ranging between 30 and 58% in patients with liver metastases of CRC.
The optimal timing of liver resection, resection of the primary tumor and neoadjuvant chemotherapy has not been fully established, yet, neither for initially resectable synchronous liver metastases, nor for those initially unresectable which could be converted to resectability. Advocates of simultaneous resection and those of staged resection (delayed liver resection or "liver first approach"), both presented theoretical arguments in favor of each of these therapeutic strategies. Progresses in liver surgery, anesthesia, intensive care and oncology caused a paradigm shift regarding the approach of synchronous colorectal liver metastases, with simultaneous resection (SR) becoming a safer procedure in the last decade. As well, the oncologic outcomes of SR are similar to those achieved by staged resection. In this review we present the literature data concerning the results achieved by each of the currently available therapeutic approaches.

Abbreviations: CLMs - colorectal liver metastases, SCLMs - synchronous colorectal liver metastases, CRC - colorectal cancer, PVL- portal vein ligation, PVE portal vein embolization, SR simultaneous resection, DR delayed liver resection, SgR staged resections, FLR future liver remnant, CHT - chemotherapy, OS - overall survival, DFS - disease-free survival, ETS - early tumor shrinkage

Full Text Sources: Download pdf
Abstract:   Abstract EN
Current Issue

June 2017


Instructions for authors
Online submission
Print ISSN: 2392-7232

Online ISSN: 2393-4999

ISSN-L: 2392-7232

Journal of Translational Medicine and Research is indexed in Scopus, CrossRef (DOI: 10.21614/jtmr)